Screener
Castle Biosciences CSTL Business Segments — Inventory usage
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept cstl:InventoryUsage.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Significant segment expenses: | ||
| Personnel costs | 58,367 | 52,200 |
| Organizational and marketing costs | 15,594 | 14,229 |
| Inventory usage | 6,437 | 4,731 |
| Clinical studies and publication costs | 2,542 | 2,085 |
| Professional services | 3,007 | 3,576 |
| Other segment items | 12,254 | 37,015 |
| Segment loss | $(14,522) | $(25,848) |
Item 1. Financial Statements.
FAQ
- What is Castle Biosciences's business segments — inventory usage?
- Castle Biosciences (CSTL) reported business segments — inventory usage of $6.44M in Q1 2026.
- How has Castle Biosciences's business segments — inventory usage changed year-over-year?
- Castle Biosciences's business segments — inventory usage increased by 36.1% year-over-year, from $4.73M to $6.44M.
- What is the long-term trend for Castle Biosciences's business segments — inventory usage?
- Over 3 years (2022 to 2025), Castle Biosciences's business segments — inventory usage has grown at a 30.3% compound annual growth rate (CAGR), from $9.86M to $21.82M.
- What does business segments — inventory usage mean?
- Reflects the cost of materials and supplies consumed during the production or delivery of diagnostic services within the segment. This is a key indicator of direct variable costs and supply chain efficiency.
Ask your AI about Castle Biosciences's business segments — inventory usage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude